Insider filing · REGN
Kathryn Guarini
Director
profile →
Regeneron Pharmaceuticals, Inc.
REGN · Healthcare · 29 filings in 24 months
ticker →
Kathryn Guarini sold $340K of Regeneron Pharmaceuticals (REGN)
Executed Sep 2, disclosed Sep 3, 1 day later.
Value, as filed
$340K
400 sh × $850.00
Executed
Sep 2
the trade date, as filed
Disclosed
Sep 3
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KGKathryn Guarini (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $340K of REGN (400 sh × $850.00, as filed), executed Sep 2.
The name
REGNHealthcare · Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Kathryn Guarini in REGN
REGNSALE
Regeneron Pharmaceuticals, Inc.
$320K400 sh × $800.00
Exec Aug 10
Filed Aug 12 · 4:16 PM ET